An observational study in Abdominal Wall Wound, sponsored by Aesculap AG. Completed at 3 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-12-13.
Sponsored by Aesculap AG · Observational
A great number of different suture techniques and suture materials are in use in order to reconstitute the abdominal wall integrity, but there is no surgical gold standard for abdominal wall closure until today. Various Meta-Analyses and randomized controlled trials have been performed, which compared non-absorbable or long-term absorbable versus rapid absorbable suture materials or monofilament versus multifilament suture materials, or continuous versus interrupted suture techniques respectively. This lack of evidence has the following outcome: burst abdomen is observed in 1-3% of patients within the first days after a laparotomy. The incidence of abdominal wall hernias 12 months postoperatively is estimated to be up to 20% (range 9 to 20%) . Wound infections develop in 3 to 21% of patients undergoing a median laparotomy within the first 30 days. At present most surgeons favour monofilament long-absorbable continuous sutures as the most suitable material for closing abdominal wounds after midline laparotomy.
Aesculap AG is the lead sponsor of 104 studies on the registry; 20 are open to participants now.
Counted across the registry records on this site, refreshed daily.
adult patients
Exclusion Criteria:
Elective primary laparotomy
Device: MonoMax
Abdominal wall will be closed with MonoMax after an elective primary laparotomy.
Frequency of reoperation due to burst abdomen
Time frame: participants will be followed for the duration of hospital stay, an expected average of 10 days
Frequency of wound infections
Time frame: participants will be followed for the duration of hospital stay, an expected average of 10 days
Incidence of wound healing until day of discharge
Time frame: participants will be followed for the duration of hospital stay, an expected average of 10 days
Length of hospital stay
Time frame: participants will be followed for the duration of hospital stay, an expected average of 10 days
Plan to share: No
This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Aesculap AG